CytoSorbents (STU:HQE1) Accumulated other comprehensive income (loss) : €1.61 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is CytoSorbents Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. CytoSorbents's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €1.61 Mil.

CytoSorbents's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2023 (€2.80 Mil) to Dec. 2023 (€0.49 Mil) but then increased from Dec. 2023 (€0.49 Mil) to Mar. 2024 (€1.61 Mil).

CytoSorbents's annual Accumulated other comprehensive income (loss) increased from Dec. 2021 (€0.47 Mil) to Dec. 2022 (€2.20 Mil) but then declined from Dec. 2022 (€2.20 Mil) to Dec. 2023 (€0.49 Mil).

CytoSorbents Accumulated other comprehensive income (loss) Historical Data

The historical data trend for CytoSorbents's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CytoSorbents Accumulated other comprehensive income (loss) Chart

CytoSorbents Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

0.47

-1.43

0.47

2.20

0.49

CytoSorbents Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															1.61	1.23	2.80	0.49	1.61

CytoSorbents Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

CytoSorbents Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of CytoSorbents's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

CytoSorbents (STU:HQE1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CytoSorbents Corp (STU:HQE1) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

CTSO:USA

Address

305 College Road East, Princeton, NJ, USA, 08540

Website

https://www.cytosorbents.com

CytoSorbents Corp is involves in the treatment of life-threatening conditions in the intensive care (ICU) and cardiac surgery using blood purification via proprietary polymer adsorption technology. It has a number of products commercialized and in development based on this technology platform.

CytoSorbents (STU:HQE1) Headlines

No Headlines